Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Dextrose 5 and potassium chloride 0 3 in plastic container?Aripiprazole generic availability 2024?Linzess generic availability 2026?Zejula patent expiry?Linzess 290 mcg price?
See the DrugPatentWatch profile for Myrbetriq
Myrbetriq (mirabegron) is a medication for overactive bladder. Its mechanism of action is based on blocking beta-3 adrenergic receptors in the bladder. By activating beta-3 signaling to relax the detrusor muscle, mirabegron helps increase bladder capacity and reduce urgency and frequency of urination [1].
Overactive bladder symptoms often relate to involuntary detrusor contractions. Mirabegron works by relaxing the detrusor (bladder) muscle through beta-3 adrenergic receptor activity, which helps the bladder store more urine before the urge to urinate occurs [1].
No. Antimuscarinics (another common overactive bladder drug class) work by blocking muscarinic receptors. Mirabegron instead targets beta-3 adrenergic receptors, so its approach is different at the receptor level [1].
Because the drug increases functional bladder capacity and reduces urgency/frequency, mirabegron is used for overactive bladder, including symptoms like urgency, frequent urination, and urge incontinence [1].
Other Questions About Myrbetriq :